(Q73980751)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

PSA doubling time of prostate carcinoma managed with watchful observation alone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

George Hruby

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

R Choo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

G DeBoer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

L Klotz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

C Danjoux

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

E Rakovitch

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

N Fleshner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

P Bunting

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

L Kapusta

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

English

0 references

publication date

1 July 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

8 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

615-620

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

Proceedings: Etiology, epidemiology, and pathology of prostatic cancer.

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901511-5

7 January 2021

Latent prostatic cancer in a consecutive autopsy series

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901511-5

7 January 2021

Natural History of Changes in Prostate Specific Antigen in Early Stage Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901511-5

7 January 2021

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901511-5

7 January 2021

Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901511-5

7 January 2021

Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901511-5

7 January 2021

Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901511-5

7 January 2021

Observations of pretreatment prostate-specific antigen doubling time in 107 patients referred for definitive radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901511-5

7 January 2021

Pretreatment prostate specific antigen doubling times: use in patients before radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901511-5

7 January 2021

Prostate specific antigen velocity as a measure of the natural history of prostate cancer: defining a 'rapid riser' subset

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901511-5

7 January 2021

10.1016/S0360-3016(01)01511-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11395227%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference